Pregnant individuals and families caring for children with chronic health conditions often face complex medical decisions. Genetic testing can offer important clues, but understanding the results is key. A single-center trial looked at how to share these results most effectively. Participants received their genetic test results alone in one group. Another group got the same results plus an educational video and counseling about the testing. The goal was to see if this extra support helped people grasp the information and feel the tests were more useful. The study found that the group with the video and counseling did better. They showed greater understanding of the genetic information and perceived higher utility from the tests. This approach addresses a real need for clear communication during a stressful time. While the study did not report on safety issues or specific adverse events, the focus remained on how well families could process the data. The researchers did not report a specific sample size or follow-up duration in the available details. Despite these gaps, the findings suggest that simple tools like videos can make a difference. For families navigating chronic conditions, clearer explanations can turn confusing data into actionable knowledge. This small change in how results are delivered could help everyone feel more confident in their care.
PGx testing with education improved understanding and perceived utility compared to test results alone in a randomized trialAdding a video and counseling helps families understand genetic test results better
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This single-center randomized control trial evaluated the impact of pharmacogenomic (PGx) testing strategies on patient comprehension. The study population consisted of pregnant individuals and families or guardians of children with a chronic health condition aged 0-16. The sample size was not reported. Participants were randomized to receive either PGx testing with return of results and an educational video about PGx testing, or PGx test results alone.
The primary outcome measured was patients' understanding and perceived utility of PGx testing. Secondary outcomes included participants' knowledge and attitudes regarding PGx testing at baseline and after receiving results. However, the main results section of the provided evidence did not contain specific numerical data, percentages, or p-values to report on these outcomes.
Safety and tolerability data, including adverse events, serious adverse events, discontinuations, and overall tolerability, were not reported. The follow-up duration was not reported. Funding or conflicts of interest were not reported. Specific limitations regarding the study design or population were not listed in the provided input.
Practice relevance was not reported. Given the lack of numerical results and safety data, the clinical utility of adding an educational video to PGx testing results remains uncertain based on this specific evidence summary.
View Original Abstract ↓
High-Dose Vitamin D and Low-Dose Vitamin A May Reduce Bronchopulmonary Dysplasia in Preterm Infants
High-Dose Vitamin D May Reduce BPD in Preterm Infants
Related in Pediatrics
From Other Specialties
